Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2019-11-18
Original SEC Filing: Click here

---

Webplus: SVA/20191118/6-K_1/2_EX-99.1/000.htm SEC Original: tm1923255d1_ex99-1.htm
Sinovac Reports Unaudited Third Quarter 2019 Financial Results BEIJING, China, Novermber 15, 2019 /Business Wire/ — Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the third quarter ended September 30, 2019. Third Quarter and First Nine Months of 2019 Financial Summary · Sales for

---

---

Webplus: SVA/20191118/6-K_1/1/000.htm SEC Original: tm1923255-1_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2019-11-18CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 15 ZHI TONG ROAD,, ZHONGGUANCUN TECH PARK, CHANGPING DISTR.
BEIJING 102200